Sometimes the most meaningful moments of care happen when someone simply takes the time to be present. While making her regular rounds at Texas Children’s Hospital, The Woodlands, Environmental Services (EVS) Houskeeper Maruja Caballero, heard a young patient crying. When she arrived at his room to collect the trash, she stopped in her tracks and moved into action to help. …
Novartis said its RNA therapy del-brax met goals of a Phase 1/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis’s $12 billion acquisition of Avidity Biosciences. The post Novartis RNA Med From $12B Deal Keeps Building Case to…
The Medicare Part D program provides an outpatient prescription drug benefit to 56 million older adults and people with long-term disabilities in Medicare who enroll in private plans. This brief analyzes Medicare Part D enrollment, premiums, and cost sharing in 2026 and trends over time, based on data from the Centers for Medicare & Medicaid…
The private plans that offer the Medicare Part D benefit – stand-alone drug plans and Medicare Advantage drug plans – are increasingly are competing on uneven terms, in part because the payment system for Medicare Advantage plans enables them to lower Part D premiums or reduce Part D cost sharing, making drug coverage from Medicare…
The next phase of AI in healthcare is about building systems where human clinicians, supervisors, and AI can all contribute, challenge each other, and improve how decisions are made. The post From Copilots to Clinical Judgment: The Next Phase of AI in Digital Behavioral Health appeared first on MedCity News.
AI is not driving healthcare cost inflation. It is exposing a system that has always been designed to reward it, and making that system more efficient. As long as reimbursement is tied to intensity, every technological advancement will move in the same direction: toward maximizing it. The post AI Is Scaling Healthcare Costs Because the…
EHR switching involves risk. But taking a life cycle view, considering data migration, workflow configuration, training, downtime, ongoing fees and eventual exit terms, can put an end to your EHR pain. The post What Healthcare Leaders Get Wrong About EHR Switching appeared first on MedCity News.
This interactive tracks announced insurer exits from and entries into the ACA Marketplaces for 2027.
This brief features maps showing how insurer participation has changed at the state and county level from 2025 to 2026 as well as insight into the number of issuers offering plans at specific metal levels.
Two recent federal actions, including a memo about alleged COVID-19 vaccine deaths and settlements creating a “detransition clinic,” show how official actions can present uncertain or uncommon outcomes as representative and lend credibility to narratives that go beyond what evidence supports.